JOURNAL ARTICLE

Research Findings from Maastricht University Update Understanding of Psychology (Evaluation of the peak experience scale as a rapid assessment tool for the strength of a psychoactive experience with 5-MeO-DMT).

Published In: Psychology & Psychiatry Journal, 2025. P. 369 1 of 2
Database: Psychology Source 2 of 2

Abstract

The article discusses a study that developed a three-item Peak Experience Scale (PES) to evaluate the strength of the psychoactive experience associated with the psychedelic 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT). Conducted at Maastricht University, the research involved administering a 5-MeO-DMT formulation to healthy volunteers and patients with treatment-resistant depression, assessing their experiences using the PES alongside other established questionnaires. The findings indicated that the PES effectively measures the intensity of the psychedelic experience, showing strong internal consistency and high correlation with other assessment tools. The PES may serve as a rapid assessment tool to guide dosing in clinical settings for psychedelics. [Extracted from the article]

Additional Information

Source:Psychology & Psychiatry Journal. 2025/06, p369
Document Type:Article
Subject Area:Health and Medicine
Publication Date:2025
ISSN:1944-2718
Accession Number:185914617
Copyright Statement:Copyright of Psychology & Psychiatry Journal is the property of NewsRx and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.